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Background and Aims: In a randomised, multi-center trial the effect of a structured 
education and treatment programme to promote self-management and empowerment for 
type 1 diabetic patients (PRIMAS) was compared to an established education programme 
(structured education and treatment programme for type 1 diabetic patients) as an active 
control group (CG). Besides optimising insulin treatment by testing basal insulin doses 
and carbohydrate factors as well as avoiding acute and late complications, the PRIMAS 
programme also aims at motivational factors and the daily routine of living with diabetes.
Materials and Methods: The primary outcome was the impact of both interventions on 
overall glycaemic control six months after the end of the diabetes education programmes. 
Secondary outcomes were diabetes related distress (Diabetes Distress Scale, 17 items), 
extent of self-perceived empowerment (Empowerment Scale, 11 items), self-efficacy 
for diabetes management (Self-Efficacy Scale, 10 items), satisfaction with insulin 
treatment (Insulin Treatment Experience Questionaire), diabetes knowledge (Knowledge 
Test, 11 items), self-care behaviour (Summary of Diabetes Self-Care Activity Scale), 
hypoglycaemia awareness (Hypoglycaemia Unawareness Questionnaire) and incidence 
of severe hypoglycaemic episodes (required third party assistance). Statistical analyses 
were adjusted for baseline values. Intention to treat analyses were performed.
Results: A total of 160 patients with type 1 diabetes (see table 1) recruited 
in diabetologist practices were randomised to either PRIMAS or the CG (see figure 
1). Main outcome was the HbA1c 6 months after participation in the respective 
programme. Baseline adjusted HbA1c was significantly more improved in PRIMAS 
than in the CG, whereas total insulin doses were highly comparable (see figure 2). 
Also empowerment and self-efficacy for diabetes management was significantly 
more increased in PRIMAS than in the CG (see figure 3). Participants in PRIMAS 
were also significantly more satisfied with their insulin therapy and reported less 
diabetes related distress than members of the CG (see figure 4). There was no 
specific impact of both education programmes on diabetes knowledge and self-care 
behaviour (see figure 5). There was also a comparable reduction of hypoglycaemia 
unawareness and on the incidence of severe hypoglycaemic episodes in both groups 
(see figure 6).
Conclusion: Although baseline HbA1c were remarkable lower than in former evaluation 
studies of type 1 diabetic education programmes, PRIMAS was more effective in lowering 
HbA1c than the established education programme. In addition, PRIMAS has proven 
its efficacy regarding the improvement of empowerment, self-efficacy and satisfaction 
with insulin treatment as well as regarding the reduction of diabetes related distress. 
The effects on knowledge and self-care behaviour are similar to those of the established 
education programme. The prevalence of severe hypoglycaemic episodes requiring 
third party assistance was rather low at baseline. However, both intervention groups 
were able to reduce the number of severe hypoglycaemic episodes even further. Thus, 
PRIMAS was able to improve glycaemic control, while also reducing the prevalence of 
hypoglycaemia problems. In summary PRIMAS has proven some advantages compared 
to the established diabetes education programme for type 1 diabetic patients with regard 
to glycaemic control, higher empowerment and self-efficacy of diabetes management as 
well as satisfaction with insulin treatment and reduction of diabetes related distress (see 
table 2). Thus, PRIMAS provides a good alternative for the treatment and education of 
type 1 diabetic patients. 
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